InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Choi Jung. Director active across 1 company, notably Global Blood Therapeutics, Inc.. In total, 15 filings have been recorded. Split: 1 buy · 0 sell. Activity tracked since 31 August 2021. The latest transaction was filed on 27 September 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations15 total
226,672 sharesCommon StockSEC:0000899243-22-033148:0
16,902 shares@ US$16.4098.2% of flowCommon StockSEC:0000899243-22-032260:0
2,763 sharesCommon StockSEC:0000899243-22-030474:0
6,145 sharesCommon StockSEC:0000899243-22-027636:0
2,763 sharesCommon StockSEC:0000899243-22-009253:0
9,020 sharesCommon StockSEC:0000899243-22-004633:0
9,020 sharesCommon StockSEC:0000899243-22-004633
9,020 sharesCommon StockSEC:0000899243-21-037669:0
9,020 sharesCommon StockSEC:0000899243-21-037669
128 shares@ US$24.3950.0% of flowCommon StockSEC:0000899243-21-035224:0
128 shares@ US$24.390.9% of flowCommon StockSEC:0000899243-21-035224
9,020 sharesCommon StockSEC:0000899243-21-031358
9,020 sharesCommon StockSEC:0000899243-21-031358:0
749 sharesCommon StockSEC:0000899243-16-012663:0
25,000 sharesCommon StockSEC:0000899243-16-011354:0
Ideal exit: 13 May 2016 (T+270)
15 of 15 declarations
About Choi Jung
Choi Jung is a director at Global Blood Therapeutics, Inc.
